NCT05824260

Brief Summary

Post-operative morbidity and mortality is related to many factors related to the patient's condition, the intra-operative period and the optimisation of intra-operative haemodynamic and respiratory parameters. Many studies have looked at the determinants and factors that increase postoperative complications. However, these have been randomised studies looking at one parameter in particular. This analysis would be the first to investigate the determinants of postoperative complications in a large population of patients undergoing major non-cardiac surgery. This is a post-hoc analysis of patients included in the OPHIQUE study, whose main objective was to evaluate intraoperative haemodynamic management guided by a marker of tissue hypoperfusion (the respiratory quotient).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 23, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 21, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

April 27, 2023

Status Verified

March 1, 2023

Enrollment Period

4 months

First QC Date

March 28, 2023

Last Update Submit

April 25, 2023

Conditions

Keywords

Goal directed therapypostoperative morbi-mortalityindividualised target

Outcome Measures

Primary Outcomes (2)

  • NUmber of risk factors associated with postoperative morbidity in major non-cardiac surgery

    2 years

  • Number of risk factors associated with postoperative mortality in major non-cardiac surgery

    2 years

Secondary Outcomes (1)

  • Number of risk factors associated with the occurrence of postoperative renal dysfunction.

    2 years

Study Arms (2)

patients with complications

patients without complication

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Abdominal, orthopaedic or vascular surgery under general anaesthesia and with an estimated duration of surgery \> 2 hours * Adult patients (age ≥ 18 years) * ASA score ≥ II * Patient with at least two of the following comorbidities: age \> 50 years, high blood pressure (HTA), heart failure, ECG abnormality, smoking, stroke, transient ischemic attack (TIA), peripheral arterial disease (PAD), insulin-dependent or non-insulin-dependent diabetes mellitus (NIDDM), ascites, chronic renal failure (CRF)

You may qualify if:

  • Abdominal, orthopaedic or vascular surgery under general anaesthesia and with an estimated duration of surgery \> 2 hours
  • Adult patients (age ≥ 18 years)
  • ASA score ≥ II
  • Patient with at least two of the following comorbidities: age \> 50 years, high blood pressure (HTA), heart failure, ECG abnormality, smoking, stroke, transient ischemic attack (TIA), peripheral arterial disease (PAD), insulin-dependent or non-insulin-dependent diabetes mellitus (NIDDM), ascites, chronic renal failure (CRF)
  • Signature of the consent form
  • Affiliation to a social security scheme

You may not qualify if:

  • Severe untreated or unbalanced hypertension
  • Preoperative renal failure on dialysis
  • Acute heart failure
  • Acute coronary insufficiency
  • Vascular surgery with renal plasty
  • Cardiac surgery
  • Permanent laparoscopy
  • Chronic respiratory failure with home oxygen therapy
  • Acute respiratory distress syndrome with FiO2\>60%.
  • Preoperative shock
  • Surgery under spinal anaesthesia and epidural only
  • Refusal to participate by the patient
  • Pregnant, parturient or breastfeeding women
  • Patients under guardianship or curators, under court protection or deprived of public rights
  • The patient already included in another therapeutic trial with an experimental molecule
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens-Picardie

Amiens, 80054, France

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2023

First Posted

April 21, 2023

Study Start

June 23, 2022

Primary Completion

October 21, 2022

Study Completion

July 1, 2023

Last Updated

April 27, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations